The United States market remained flat over the last week but has risen 8.1% in the past 12 months, with earnings expected to grow by 14% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability within a stable economic backdrop.
Top 10 High Growth Tech Companies In The United States
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| TG Therapeutics | 26.18% | 37.61% | ★★★★★★ |
| Alkami Technology | 20.45% | 85.16% | ★★★★★★ |
| Travere Therapeutics | 28.43% | 65.01% | ★★★★★★ |
| Clene | 61.16% | 59.11% | ★★★★★★ |
| Alnylam Pharmaceuticals | 22.82% | 58.64% | ★★★★★★ |
| AVITA Medical | 27.75% | 55.36% | ★★★★★★ |
| Applied Optoelectronics | 58.93% | 141.15% | ★★★★★★ |
| TKO Group Holdings | 22.54% | 25.17% | ★★★★★★ |
| Lumentum Holdings | 21.55% | 119.67% | ★★★★★★ |
| Ascendis Pharma | 32.36% | 59.79% | ★★★★★★ |
Click here to see the full list of 235 stocks from our US High Growth Tech and AI Stocks screener.
Let's uncover some gems from our specialized screener.
Cellebrite DI (NasdaqGS:CLBT)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Cellebrite DI Ltd. provides solutions for legally sanctioned investigations across various regions including Europe, the Middle East, Africa, the Americas, and Asia-Pacific, with a market cap of $4.07 billion.
Operations: Cellebrite DI Ltd. generates revenue primarily from its Internet Software & Services segment, amounting to $401.20 million.
Cellebrite DI, amidst a transformative phase, reported a significant rebound with fourth-quarter revenues soaring to $109.05 million from $93.01 million the previous year and flipping a net loss into a profit of $19.27 million. This turnaround is underscored by an aggressive R&D strategy that not only fuels innovation but also aligns with industry shifts towards more secure and efficient digital forensics solutions. The appointment of tech veteran Michael D. Capellas to the board promises enhanced governance, potentially steering Cellebrite towards sustained growth, especially with projected annual revenue growth at 15.3%, outpacing the US market's 8.5%. This trajectory suggests robust future prospects, albeit in the challenging landscape of high-tech investment where rapid evolution and competition are constants.
- Navigate through the intricacies of Cellebrite DI with our comprehensive health report here.
Gain insights into Cellebrite DI's historical performance by reviewing our past performance report.
Lumentum Holdings (NasdaqGS:LITE)
Simply Wall St Growth Rating: ★★★★★★
Overview: Lumentum Holdings Inc. is a company that manufactures and sells optical and photonic products across various regions including the Americas, Asia-Pacific, Europe, the Middle East, and Africa with a market capitalization of $4.72 billion.
Operations: Lumentum generates revenue primarily from its Cloud & Networking segment, which accounts for $1.19 billion, and the Industrial Tech segment, contributing $223.9 million.
Lumentum Holdings, recently chosen by NVIDIA to enhance its silicon photonics ecosystem, underscores its pivotal role in advancing AI infrastructure with innovative laser technologies. This collaboration is set to reduce power consumption significantly, boosting the efficiency of next-gen networking switches—a critical factor as the industry shifts towards more sustainable and robust data center solutions. Despite facing a net loss in recent quarters, Lumentum's strategic partnerships and expected revenue growth of 21.6% annually position it for potential recovery and growth in a highly competitive sector.
- Get an in-depth perspective on Lumentum Holdings' performance by reading our health report here.
Examine Lumentum Holdings' past performance report to understand how it has performed in the past.
HubSpot (NYSE:HUBS)
Simply Wall St Growth Rating: ★★★★★☆
Overview: HubSpot, Inc. offers a cloud-based CRM platform for businesses across the Americas, Europe, and the Asia Pacific with a market cap of $31.97 billion.
Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $2.63 billion.
HubSpot, a CRM powerhouse, recently showcased its robust growth trajectory and strategic market positioning. By joining forces with Sales Focus Inc., HubSpot not only extends its reach within the Solutions Partner Program but also enhances its capabilities in driving customer engagement and sales efficiency through advanced CRM solutions. This collaboration is poised to fortify HubSpot's service offerings across the entire customer experience spectrum. Financially, HubSpot turned a corner this past year, transitioning from a net loss to reporting a net income of $4.94 million in Q4 2024, with annual revenue hitting $2.63 billion—a significant leap from the previous year's $2.17 billion. Looking ahead, HubSpot projects revenue growth between 13% to 16%, signaling strong forward momentum in an increasingly competitive landscape.
- Dive into the specifics of HubSpot here with our thorough health report.
Assess HubSpot's past performance with our detailed historical performance reports.
Make It Happen
- Access the full spectrum of 235 US High Growth Tech and AI Stocks by clicking on this link.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Contemplating Other Strategies?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if HubSpot might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com